Pharma & tech sectors likely to be impacted the most, finds a study Come April 2016, investors may find it less tedious to compare earnings of listed companies with the new Indian accounting standard -Ind-AS -set to be implemented. But, the transparency will come at a cost. Profitability of many companies could be impacted heavily because of the new rules. A study by brokerage Ambit Capital of companies that are part of the Nifty shows that sectors such as pharma and technology along with conglomerates will be most impacted. Among companies, Tata Motors, Wipro and Dr Reddy's could see lower profits under the new accounting standards, said Ambit. More than 500 listed Indian companies (comprising about 75% of the total market capitalisation) will adopt Ind-AS. Several consultants said investors and analysts may need to brace for sharp variations in earnings from what they had estimated. “Next year many companies' results would look very different, as you would have di